A 60-month Non-comparative Study on Bleeding Profiles With Levonorgestrel Intrauterine System in Transition From Reproductive Age Contraception to Menopause Age Endometrial Protection During Estrogen Replacement Therapy.
Phase of Trial: Phase III
Latest Information Update: 26 Nov 2013
At a glance
- Drugs Levonorgestrel (Primary)
- Indications Pregnancy
- Focus Pharmacodynamics; Registrational
- Sponsors Bayer HealthCare Pharmaceuticals
- 01 Dec 2011 Actual patient number is 394 according to ClinicalTrials.gov.
- 30 Oct 2008 Actual number of patients (396) added as reported by CT.gov
- 01 Oct 2008 Actual end date (May 2008) added as reported by CT.gov